Lior Levanoni

Artfix Ltd. is a medical device company focused on the field of electrophysiology.

Artfix is aiming to bring a real breakthrough one-shot treatment for the atrial fibrillation market with a unique cryo ablation catheter.

The main advantages of the Artfix system are safety- using a controlled cryo ablation system that has fewer complication rates than other types of ablation, Efficacy – cooling tip creates by design a continuous line with full contact of the tissue, this contact allows Artfix to perform a continuous transmural ablation. Usability – performs a real “one-shot” procedure, sparing the need to use a 3D mapping system.

Artfix can perform a box/linear lesion which will allow treatment both paroxysmal and persistent, patients